| Baseline VA letters, mean (SD) (Snellen equivalent) | 6-month VA letters, mean (SD) (Snellen equivalent) | Change | p Value | |
| All patients (n = 17) | 42.7 (17.6) (20/160+2) | 51.1 (20.8) (20/100+1) | +8.4 | 0.04 |
| Untreated CNV (n = 8) | 39.1 (17.9) (20/160−1) | 48.7 (20.7) (20/100−2) | +9.6 | 0.13 |
| Previous PDT (n = 9) | 46.0 (17.7) (20/126+1) | 53.3 (21.9) (20/80−2) | +7.3 | 0.09 |
| Age⩽50 years (n = 6) | 53.1 (14.4) (20/80−2) | 61.8 (14.0) (20/63+1) | +8.7 | 0.13 |
| Age>50 years (n = 11) | 37.0 (17.1) (20/200+2) | 45.3 (22.1) (20/126) | +8.3 | 0.1 |
| Baseline foveal thickness (μm), mean (SD) | 6-month foveal thickness (μm), mean (SD) | Change | p Value | |
| All patients (n = 17) | 282.7 (101.4) | 203.1 (41.1) | −79.6 | 0.002 |
| Untreated CNV (n = 8) | 325.7 (138.0) | 216.6 (37.9) | −109.1 | 0.03 |
| Previous PDT (n = 9) | 244.5 (19.7) | 191.1 (42.2) | −53.4 | 0.003 |
| Age⩽50 years (n = 6) | 281.6 (96.9) | 211.6 (51.6) | −70 | 0.03 |
| Age>50 years (n = 11) | 283.3 (108.4) | 198.4 (36.1) | −84.9 | 0.01 |
CNV, choroidal neovascularisation; PDT, photodynamic therapy; VA, visual acuity.